)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Scribe Therapeutics
Scribe Therapeutics (SCRE) investor relations material
Scribe Therapeutics has been private
Scribe Therapeutics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary2 Jul, 2026
Company overview and business model
Clinical-stage biotech focused on in vivo CRISPR technologies for common diseases, especially cardiovascular and metabolic conditions.
Lead program STX-1150 targets LDL-C via epigenetic silencing of PCSK9; additional programs target Lp(a) and triglycerides.
Proprietary CRISPR by Design approach leverages AI, machine learning, and parallel validation to engineer therapies.
Strategic collaborations with Sanofi and Lilly in rare genetic and neurological diseases; pipeline expansion planned.
Founded by leaders in CRISPR, including Nobel Laureate Dr. Jennifer Doudna; strong IP portfolio based on CasX enzyme.
Financial performance and metrics
Collaboration revenue: $51.2M in 2025, $27.4M in 2024; $2.2M in Q1 2026.
Net loss: $21.8M in 2025, $47.8M in 2024; $17.4M loss in Q1 2026.
Accumulated deficit: $175.1M as of March 31, 2026.
Cash, cash equivalents, and investments: $49.7M as of March 31, 2026.
Substantial doubt about ability to continue as a going concern; additional capital needed beyond IPO proceeds.
Use of proceeds and capital allocation
Net proceeds to fund clinical development of STX-1150, advance STX-1200 and STX-1400, invest in pipeline and technology, and for working capital.
Proceeds may also be used for in-licensing, acquisitions, or investments in complementary technologies.
Existing cash plus IPO proceeds expected to fund operations through a defined period, but not through regulatory approval of any program.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Scribe Therapeutics
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage